Comparative efficacy, tolerability and treatment adherence of oral and long acting injectable antipsychotic in first episode schizophrenia.

Government Medical College and Hospital Chandigarh Sector0 sites0 target enrollmentTBD

Overview

No summary available.

Registry

who.int

Start Date

TBD

End Date

TBD

Last Updated

4 years ago

Study Type

Interventional

Sponsor

Government Medical College and Hospital Chandigarh Sector

•1\)Patients diagnosed with schizophrenia as per DSM\-5
•2\)Total duration of illness shall be less than one year.
•3\)Age of the patients shall be between 18\-45 years.
•4\)Drug naÃ¯ve or not on any psycho tropics for 2 weeks.
•5\)Patients willing to participate and give consent or in case the patient lacks mental capacity, his/her nominated representative gives consent to participate.

•1\)Patients who are not willing to give consent.
•2\)Pregnant and breast feeding patients.
•3\)Patients with co\-morbid psychiatric illness and substance dependence.
•4\)Patients with severe medical and surgical illness.
•5\)Patients with high suicidal risk( Beckâ??s scale for suicidal ideation score \>29\)
•6\)Patients with history of sensitivity to haloperidol in the past.
•7\)Patients with history of depot antipsychotic administration in the past.
•8\)Patients with no response to haloperidol in the past or those reporting non\-tolerability to the drug in the past.
•9\)Patients who had received ECT in the past.

Not specified